MedPath

Colorado Prevention Center

🇺🇸United States
Ownership
Private
Established
1876-01-01
Employees
9.4K
Market Cap
-
Website
http://www.coloradopreventioncenter.org

Clinical Trials

9

Active:1
Completed:3

Trial Phases

4 Phases

Phase 1:1
Phase 3:4
Phase 4:2
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials

Phase 3
4 (44.4%)
Not Applicable
2 (22.2%)
Phase 4
2 (22.2%)
Phase 1
1 (11.1%)

A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists

Phase 3
Recruiting
Conditions
Heart Failure
Interventions
Drug: Placebo
First Posted Date
2023-09-13
Last Posted Date
2025-03-11
Lead Sponsor
Colorado Prevention Center
Target Recruit Count
2600
Registration Number
NCT06033950
Locations
🇺🇸

FIN-10004 Fairhope, AL Investigational Site, Fairhope, Alabama, United States

🇺🇸

FIN-10075 San Diego, CA Investigational Site, San Diego, California, United States

🇺🇸

FIN-10015 Austin, TX Investigational Site, Austin, Texas, United States

and more 5 locations

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients with Heart Failure (CONFIRMATION-HF)

Phase 3
Recruiting
Conditions
Heart Failure
Interventions
First Posted Date
2023-09-06
Last Posted Date
2025-03-11
Lead Sponsor
Colorado Prevention Center
Target Recruit Count
1500
Registration Number
NCT06024746
Locations
🇺🇸

CON-10004 Fairhope, AL Investigational Site, Fairhope, Alabama, United States

🇺🇸

CON-10075 El Centro, CA Investigational Site, El Centro, California, United States

🇺🇸

CON-10024 Sacramento, CA Investigational Site, Sacramento, California, United States

and more 12 locations

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

Phase 3
Recruiting
Conditions
Heart Failure
Acute Heart Failure
Interventions
Drug: Placebo
First Posted Date
2023-08-23
Last Posted Date
2024-03-01
Lead Sponsor
Colorado Prevention Center
Target Recruit Count
5200
Registration Number
NCT06008197
Locations
🇺🇸

Aurora, CO Investigative Site, Aurora, Colorado, United States

🇺🇸

Denver, CO Investigative Site, Denver, Colorado, United States

🇺🇸

Boca Raton, FL Investigative Site, Boca Raton, Florida, United States

and more 1 locations

Virta Intervention in CommuniTies in COloRado (VICTOR-Pilot)

Not Applicable
Completed
Conditions
Diabetes Mellitus, Type 2
First Posted Date
2021-03-19
Last Posted Date
2025-03-11
Lead Sponsor
Colorado Prevention Center
Target Recruit Count
51
Registration Number
NCT04807218
Locations
🇺🇸

Northwest Colorado Health - Community Health Center & Prevention Services Craig, Craig, Colorado, United States

🇺🇸

High Plains Community Health Center, Lamar, Colorado, United States

🇺🇸

Chaffee County Public and Environmental Health, Salida, Colorado, United States

Implementation of Vascular Care Team to Improve Medical Management of PAD Patients

Not Applicable
Completed
Conditions
Peripheral Artery Disease
First Posted Date
2020-05-22
Last Posted Date
2024-02-08
Lead Sponsor
Colorado Prevention Center
Target Recruit Count
166
Registration Number
NCT04400409
Locations
🇺🇸

University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States

  • Prev
  • 1
  • 2
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath